Y. YILMAZ Et Al. , "Impairment of patient-reported outcomes among patients with non-alcoholic fatty liver disease: a registry-based study," ALIMENTARY PHARMACOLOGY & THERAPEUTICS , vol.57, no.2, pp.215-223, 2023
YILMAZ, Y. Et Al. 2023. Impairment of patient-reported outcomes among patients with non-alcoholic fatty liver disease: a registry-based study. ALIMENTARY PHARMACOLOGY & THERAPEUTICS , vol.57, no.2 , 215-223.
YILMAZ, Y., Toraman, A. E., Alp, C., Dogan, Z., Keklikkiran, C., Stepanova, M., ... Younossi, Z.(2023). Impairment of patient-reported outcomes among patients with non-alcoholic fatty liver disease: a registry-based study. ALIMENTARY PHARMACOLOGY & THERAPEUTICS , vol.57, no.2, 215-223.
YILMAZ, YUSUF Et Al. "Impairment of patient-reported outcomes among patients with non-alcoholic fatty liver disease: a registry-based study," ALIMENTARY PHARMACOLOGY & THERAPEUTICS , vol.57, no.2, 215-223, 2023
YILMAZ, YUSUF Et Al. "Impairment of patient-reported outcomes among patients with non-alcoholic fatty liver disease: a registry-based study." ALIMENTARY PHARMACOLOGY & THERAPEUTICS , vol.57, no.2, pp.215-223, 2023
YILMAZ, Y. Et Al. (2023) . "Impairment of patient-reported outcomes among patients with non-alcoholic fatty liver disease: a registry-based study." ALIMENTARY PHARMACOLOGY & THERAPEUTICS , vol.57, no.2, pp.215-223.
@article{article, author={YUSUF YILMAZ Et Al. }, title={Impairment of patient-reported outcomes among patients with non-alcoholic fatty liver disease: a registry-based study}, journal={ALIMENTARY PHARMACOLOGY & THERAPEUTICS}, year=2023, pages={215-223} }